tiprankstipranks
Trending News
More News >
MacroGenics Inc (MGNX)
NASDAQ:MGNX
US Market

MacroGenics (MGNX) Stock Forecast & Price Target

Compare
705 Followers
See the Price Targets and Ratings of:

MGNX Analyst Ratings

Hold
1Ratings
Hold
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
MacroGenics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MGNX Stock 12 Month Forecast

Average Price Target

$4.00
▲(131.21% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for MacroGenics in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 131.21% change from the last price of $1.73.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","5":"$5","1.25":"$1.25","2.5":"$2.5","3.75":"$3.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.25,2.5,3.75,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.75,1.9230769230769231,2.0961538461538463,2.269230769230769,2.4423076923076925,2.6153846153846154,2.7884615384615383,2.9615384615384617,3.1346153846153846,3.3076923076923075,3.480769230769231,3.6538461538461537,3.8269230769230766,{"y":4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.75,1.9230769230769231,2.0961538461538463,2.269230769230769,2.4423076923076925,2.6153846153846154,2.7884615384615383,2.9615384615384617,3.1346153846153846,3.3076923076923075,3.480769230769231,3.6538461538461537,3.8269230769230766,{"y":4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.75,1.9230769230769231,2.0961538461538463,2.269230769230769,2.4423076923076925,2.6153846153846154,2.7884615384615383,2.9615384615384617,3.1346153846153846,3.3076923076923075,3.480769230769231,3.6538461538461537,3.8269230769230766,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.46,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.22,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 58, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.66,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 59, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.46,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 45, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.61,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.75,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$4.00Average Price Target$4.00Lowest Price Target$4.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on MGNX
Stifel Nicolaus
Stifel Nicolaus
$4
Hold
131.21%
Upside
Reiterated
02/24/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Barclays Analyst forecast on MGNX
Barclays
Barclays
$3
Buy
73.41%
Upside
Reiterated
11/13/25
MacroGenics (MGNX) Gets a Buy from Barclays
TD Cowen
Hold
Reiterated
11/12/25
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
H.C. Wainwright Analyst forecast on MGNX
H.C. Wainwright
H.C. Wainwright
$2
Hold
15.61%
Upside
Reiterated
10/31/25
MacroGenics (MGNX) Receives a Hold from H.C. Wainwright
Roth MKM Analyst forecast on MGNX
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$3
Buy
73.41%
Upside
Initiated
09/17/25
MacroGenics (MGNX) Initiated with a Buy at Roth MKM
Leerink Partners Analyst forecast on MGNX
Leerink Partners
Leerink Partners
$8$5
Buy
189.02%
Upside
Reiterated
08/18/25
MacroGenics price target lowered to $5 from $8 at LeerinkMacroGenics price target lowered to $5 from $8 at Leerink
Citizens JMP Analyst forecast on MGNX
Citizens JMP
Citizens JMP
Hold
Reiterated
08/15/25
Citizens JMP Keeps Their Hold Rating on MacroGenics (MGNX)
B. Riley Securities Analyst forecast on MGNX
B. Riley Securities
B. Riley Securities
$5$3
Hold
73.41%
Upside
Reiterated
05/20/25
MacroGenics price target lowered to $3 from $5 at B. RileyMacroGenics price target lowered to $3 from $5 at B. Riley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on MGNX
Stifel Nicolaus
Stifel Nicolaus
$4
Hold
131.21%
Upside
Reiterated
02/24/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Barclays Analyst forecast on MGNX
Barclays
Barclays
$3
Buy
73.41%
Upside
Reiterated
11/13/25
MacroGenics (MGNX) Gets a Buy from Barclays
TD Cowen
Hold
Reiterated
11/12/25
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
H.C. Wainwright Analyst forecast on MGNX
H.C. Wainwright
H.C. Wainwright
$2
Hold
15.61%
Upside
Reiterated
10/31/25
MacroGenics (MGNX) Receives a Hold from H.C. Wainwright
Roth MKM Analyst forecast on MGNX
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$3
Buy
73.41%
Upside
Initiated
09/17/25
MacroGenics (MGNX) Initiated with a Buy at Roth MKM
Leerink Partners Analyst forecast on MGNX
Leerink Partners
Leerink Partners
$8$5
Buy
189.02%
Upside
Reiterated
08/18/25
MacroGenics price target lowered to $5 from $8 at LeerinkMacroGenics price target lowered to $5 from $8 at Leerink
Citizens JMP Analyst forecast on MGNX
Citizens JMP
Citizens JMP
Hold
Reiterated
08/15/25
Citizens JMP Keeps Their Hold Rating on MacroGenics (MGNX)
B. Riley Securities Analyst forecast on MGNX
B. Riley Securities
B. Riley Securities
$5$3
Hold
73.41%
Upside
Reiterated
05/20/25
MacroGenics price target lowered to $3 from $5 at B. RileyMacroGenics price target lowered to $3 from $5 at B. Riley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MacroGenics

3 Months
xxx
Success Rate
6/14 ratings generated profit
43%
Average Return
+0.34%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +0.34% per trade.
1 Year
Etzer DaroutBarclays
Success Rate
7/14 ratings generated profit
50%
Average Return
+6.78%
reiterated a buy rating 4 months ago
Copying Etzer Darout's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +6.78% per trade.
2 Years
xxx
Success Rate
3/14 ratings generated profit
21%
Average Return
-38.32%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 21.43% of your transactions generating a profit, with an average return of -38.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MGNX Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
4
4
1
1
0
Buy
0
0
0
0
0
Hold
58
59
45
20
10
Sell
7
15
13
11
2
Strong Sell
0
0
0
0
0
total
69
78
59
32
12
In the current month, MGNX has received 0 Buy Ratings, 10 Hold Ratings, and 2 Sell Ratings. MGNX average Analyst price target in the past 3 months is 4.00.
Each month's total comprises the sum of three months' worth of ratings.

MGNX Financial Forecast

MGNX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

MGNX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

MGNX Stock Forecast FAQ

What is MGNX’s average 12-month price target, according to analysts?
Based on analyst ratings, MacroGenics Inc’s 12-month average price target is 4.00.
    What is MGNX’s upside potential, based on the analysts’ average price target?
    MacroGenics Inc has 131.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MGNX a Buy, Sell or Hold?
          MacroGenics Inc has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
            What is MacroGenics Inc’s price target?
            The average price target for MacroGenics Inc is 4.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $4.00 ,the lowest forecast is $4.00. The average price target represents 131.21% Increase from the current price of $1.73.
              What do analysts say about MacroGenics Inc?
              MacroGenics Inc’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of MGNX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.